RecruitingNot ApplicableNCT06632886

AI-Assisted Non-Contrast CT for Multi-Cancer Screening

A Prospective Cohort Study Evaluating the Utility of Artificial Intelligence-Assisted Non-Contrast Computed Tomography for Multi-Cancer Screening in Asymptomatic Individuals Undergoing Routine Health Examinations

Sponsor

Guo ShiWei

Enrollment

1,000,000 participants

Start Date

Oct 7, 2024

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Lung Cancers Liver Cancer Gastric Cancers Colorectal, Cancer Esophageal Cancer Pancreatic Cancer

Summary

Cancer poses a major public health challenge in China. Early detection can improve treatment outcomes and survival rates. In this study, we will conduct a large-scale, prospective, multi-center cohort study to evaluate the utility of AI-assisted non-contrast CT for multi-cancer screening. The study aims to enroll 1 million asymptomatic participants undergoing routine health examinations, using an AI imaging model based on non-contrast CT to detect seven cancers such as lung, liver, gastric, colorectal, esophageal, pancreatic, and breast cancers. Positive cases will be required to be referred to Shanghai Changhai Hospital for further imaging and care based on National Comprehensive Cancer Network (NCCN) and American College of Radiology (ACR) guidelines. The goal is to assess the AI model's diagnostic performance for seven cancer types, especially for early-stage, resectable tumors.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether an AI tool can detect multiple types of cancer from a regular CT scan that does not use contrast dye. You may be eligible if: you have already had an abdominal or chest CT scan without contrast dye; and you are willing and able to give your informed consent. You may NOT be eligible if: you were diagnosed with lung, liver, stomach, colon, esophageal, pancreatic, or breast cancer in the past five years; you have a medical condition that makes high-resolution imaging unsafe for you; you cannot be reached for follow-up; or you are currently enrolled in another clinical trial. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAI-Assisted Non-Contrast CT for Multi-Cancer Screening

Participants identified by the AI model as having potential cancerous lesions, including those suspected of lung, liver, gastric, colorectal, esophageal, pancreatic, and breast cancer, will be required to undergo blood tests (for tumor markers) and additional imaging studies (such as contrast-enhanced CT, MRI, Endoscopy, etc.) to confirm the diagnosis of cancerous lesions.